patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Emma, as I have said before - company generated

"fluff" is not news. It is what it is - fluff. We need something from the medical or scientific community announcing a new breakthrough or something similar if we are going to really get moving. I am watching for a buying opportunity with little more downside. I'm just not sure we are there yet.

Kirk

Share
New Message
Please login to post a reply